JoVE Logo

Sign In

IRCCS San Raffaele Scientific Institute

5 ARTICLES PUBLISHED IN JoVE

image

Cancer Research

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Andreas Agathangelidis *1, Lesley Ann Sutton *2,3, Anastasia Hadzidimitriou 1, Cristina Tresoldi 4, Anton W. Langerak 5, Chrysoula Belessi 6, Frederic Davi 7, Richard Rosenquist 2,3, Kostas Stamatopoulos 1,2, Paolo Ghia 8
1Institute of Applied Biosciences, Centre for Research and Technology Hellas, 2Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 3Department of Molecular Medicine and Surgery, Karolinska Institutet, 4Division of Immunology, Transplantation and Infectious, IRCCS San Raffaele Scientific Institute, 5Department of Immunology, Laboratory for Medical Immunology, Erasmus University Medical Center, 6Hematology Department, Nikea General Hospital, 7Assistance publique - Hôpitaux de Paris (AP-HP), Hopital Pitié-Salpêtrière, Department of Hematology, and UPMC University Paris 06, UMRS 1138, 8Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele

Herein, we present a protocol that details the technical aspects and essential requirements to ensure robust IG gene sequence analysis in patients with chronic lymphocytic leukemia (CLL), based on the accumulated experience of the European Research initiative on CLL (ERIC).

image

Immunology and Infection

Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies
Gloria Delfanti 1, Alessandra Perini *1,2, Elisa Zappa *1,2, Maya Fedeli 1,2
1Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 2Vita-Salute San Raffaele University

We describe a rapid and robust protocol to enrich invariant natural killer T (iNKT) cells from mouse spleen and expand them in vitro to suitable numbers for in vitro and in vivo studies.

image

Medicine

Fertility Sparing Procedure using Carbon Dioxide Fiber Laser Vaporization of Ovarian Endometrioma
Massimo Candiani 1, Jessica Ottolina 1, Iacopo Tandoi 1, Ludovica Bartiromo 1, Matteo Schimberni 1, Roberta Villanacci 1, Stefano Ferrari 1
1Gynecological Surgery and Endometriosis Departmental Unit, San Raffaele Scientific Institute

In this protocol, CO2 fiber laser technique is demonstrated for the surgical treatment of ovarian endometriosis, which represents a viable alternative in terms of fertility preservation with the major advantage of not being dependent on the surgeon's skills and personal experience.

image

Medicine

Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome
Valeria Stella Vanni *1,2, Alessandra Alteri *1,2, Lucia De Santis 1,2, Greta Chiara Cermisoni 1, Elisa Rabellotti 1, Diana Delprato 1, Marta Parma 1, Enrico Papaleo 1, Luigi Fedele 3, Massimo Candiani 1,2
1Obstetrics and Gynaecology Unit, IRCCS San Raffaele Scientific Institute, 2Vita-Salute San Raffaele University, 3Department of Obstetrics and Gynecology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

A dedicated team can offer Mayer-Rokitansky-Kuster-Hauser patients the option to perform controlled ovarian stimulation and oocyte cryopreservation at the time of laparoscopic vaginoplasty.

image

Bioengineering

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Alessandro Migliara 1, Martino Alfredo Cappelluti 1, Francesca Giannese 2, Sara Valsoni 1, Alberto Coglot 1, Ivan Merelli 1,3, Davide Cittaro 2, Angelo Lombardo 1,4
1San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, 2Center for Omics Sciences, IRCCS San Raffaele Institute, 3Institute for Biomedical Technologies, National Research Council, 4Vita-Salute San Raffaele University

Here, we present a protocol for the in vitro selection of engineered transcriptional repressors (ETRs) with high, long-term, stable, on-target silencing efficiency and low genome-wide, off-target activity. This workflow allows for reducing an initial, complex repertoire of candidate ETRs to a short list, suitable for further evaluation in therapeutically relevant settings.

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved